எரேமியா தேஜேன்ஹார்ட்ட் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from எரேமியா தேஜேன்ஹார்ட்ட். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In எரேமியா தேஜேன்ஹார்ட்ட் Today - Breaking & Trending Today

Presage Sets the Stage for Commercial Expansion with Closing of $13M Financing and Execution of New Phase 0 Trial Agreements with Merck and Maverick Therapeutics


Presage Sets the Stage for Commercial Expansion with Closing of $13M Financing and Execution of New Phase 0 Trial Agreements with Merck and Maverick Therapeutics
- Funds to Support Expansion of CIVO® Technology Platform
- New Collaborations to Utilize CIVO for Phase 0 Studies
News provided by
Share this article
Share this article
SEATTLE, March 2, 2021 /PRNewswire/ Presage Biosciences, Inc., a biotechnology company pioneering a new cancer drug development approach using its Comparative
In Vivo Oncology (CIVO®) intratumoral microdosing platform, today announced the closing of a $13 million financing and commencement of new research collaborations with Merck, known as MSD outside of the United States and Canada, and Maverick Therapeutics. ....

United States , Jeremiah Degenhardt , Steve Anderson , Julie Rathbun , Labcorp Drug Development , Inharv Partners Ltd , Labcorp Venture Fund , Bristol Myers Squibb , Prnewswire Presage Biosciences Inc , Rathbun Communications , Comparative In Vivo Oncology , Inharv Partners , Takeda Ventures , Chief Scientific Officer , Labcorp Drug , Vice President , Translational Oncology , Rich Klinghoffer , Vivo Oncology , Exploratory Investigational New Drug , Presage Biosciences , ஒன்றுபட்டது மாநிலங்களில் , எரேமியா தேஜேன்ஹார்ட்ட் , ஸ்டீவ் ஆண்டர்சன் , ஜூலி ராதிபூன் , லாப்கோர்ப் மருந்து வளர்ச்சி ,